Advanced search
1 file | 2.25 MB Add to list

Clinically relevant aberrant Filip1l DNA methylation detected in a murine model of cutaneous squamous cell carcinoma

Author
Organization
Abstract
Background: Cutaneous squamous cell carcinomas (cSCC) are among the most common and highly mutated human malignancies. Understanding the impact of DNA methylation in cSCC may provide avenues for new therapeutic strategies. Methods: We used reduced-representation bisulfite sequencing for DNA methylation analysis of murine cSCC. Differential methylation was assessed at the CpG level using limma. Next, we compared with human cSCC Infinium HumanMethylation BeadArray data. Genes were considered to be of major relevance when they featured at least one significantly differentially methylated CpGs (RRBS) / probes (Infinium) with at least a 30% difference between tumour vs. control in both a murine gene and its human orthologue. The human EPIC Infinium data were used to distinguish two cSCC subtypes, stem-cell-like and keratinocyte-like tumours. Findings: We found increased average methylation in mouse cSCC (by 12.8%, p = 0.0011) as well as in stem-cell like (by 3.1%, p=0.002), but not keratinocyte-like (0.2%, p = 0.98), human cSCC. Comparison of differentially methylated genes revealed striking similarities between human and mouse cSCC. Locus specific methylation changes in mouse cSCC often occurred in regions of potential regulatory function, including enhancers and promoters. A key differentially methylated region was located in a potential enhancer of the tumour suppressor gene Filip1l and its expression was reduced in mouse tumours. Moreover, the FILIP1L, locus showed hypermethylation in human cSCC and lower expression in human cSCC cell lines. Interpretation: Deregulation of DNA methylation is an important feature of murine and human cSCC that likely contributes to silencing of tumour suppressor genes, as shown for Filip1l. 2021 The Author(s). Published by Elsevier B.V.
Keywords
cSCC, DNA methylation, RRBS, FILIP1L, INTERACTING PROTEIN 1-LIKE, DOWN-REGULATION, SKIN-CANCER, MUTATIONS, CARCINOGENESIS, INHIBITION, EXPRESSION, LANDSCAPE, RADIATION, BENEFITS

Downloads

  • Clinically relevant aberrant.pdf
    • full text (Published version)
    • |
    • open access
    • |
    • PDF
    • |
    • 2.25 MB

Citation

Please use this url to cite or link to this publication:

MLA
Roth, Kevin, et al. “Clinically Relevant Aberrant Filip1l DNA Methylation Detected in a Murine Model of Cutaneous Squamous Cell Carcinoma.” EBIOMEDICINE, vol. 67, 2021, doi:10.1016/j.ebiom.2021.103383.
APA
Roth, K., Coussement, L., Knatko, E. V., Higgins, M., Steyaert, S., Proby, C. M., … Dinkova-Kostova, A. T. (2021). Clinically relevant aberrant Filip1l DNA methylation detected in a murine model of cutaneous squamous cell carcinoma. EBIOMEDICINE, 67. https://doi.org/10.1016/j.ebiom.2021.103383
Chicago author-date
Roth, Kevin, Louis Coussement, Elena V. Knatko, Maureen Higgins, Sandra Steyaert, Charlotte M. Proby, Tim De Meyer, and Albena T. Dinkova-Kostova. 2021. “Clinically Relevant Aberrant Filip1l DNA Methylation Detected in a Murine Model of Cutaneous Squamous Cell Carcinoma.” EBIOMEDICINE 67. https://doi.org/10.1016/j.ebiom.2021.103383.
Chicago author-date (all authors)
Roth, Kevin, Louis Coussement, Elena V. Knatko, Maureen Higgins, Sandra Steyaert, Charlotte M. Proby, Tim De Meyer, and Albena T. Dinkova-Kostova. 2021. “Clinically Relevant Aberrant Filip1l DNA Methylation Detected in a Murine Model of Cutaneous Squamous Cell Carcinoma.” EBIOMEDICINE 67. doi:10.1016/j.ebiom.2021.103383.
Vancouver
1.
Roth K, Coussement L, Knatko EV, Higgins M, Steyaert S, Proby CM, et al. Clinically relevant aberrant Filip1l DNA methylation detected in a murine model of cutaneous squamous cell carcinoma. EBIOMEDICINE. 2021;67.
IEEE
[1]
K. Roth et al., “Clinically relevant aberrant Filip1l DNA methylation detected in a murine model of cutaneous squamous cell carcinoma,” EBIOMEDICINE, vol. 67, 2021.
@article{8741083,
  abstract     = {{Background: Cutaneous squamous cell carcinomas (cSCC) are among the most common and highly mutated human malignancies. Understanding the impact of DNA methylation in cSCC may provide avenues for new therapeutic strategies.
Methods: We used reduced-representation bisulfite sequencing for DNA methylation analysis of murine cSCC. Differential methylation was assessed at the CpG level using limma. Next, we compared with human cSCC Infinium HumanMethylation BeadArray data. Genes were considered to be of major relevance when they featured at least one significantly differentially methylated CpGs (RRBS) / probes (Infinium) with at least a 30% difference between tumour vs. control in both a murine gene and its human orthologue. The human EPIC Infinium data were used to distinguish two cSCC subtypes, stem-cell-like and keratinocyte-like tumours.
Findings: We found increased average methylation in mouse cSCC (by 12.8%, p = 0.0011) as well as in stem-cell like (by 3.1%, p=0.002), but not keratinocyte-like (0.2%, p = 0.98), human cSCC. Comparison of differentially methylated genes revealed striking similarities between human and mouse cSCC. Locus specific methylation changes in mouse cSCC often occurred in regions of potential regulatory function, including enhancers and promoters. A key differentially methylated region was located in a potential enhancer of the tumour suppressor gene Filip1l and its expression was reduced in mouse tumours. Moreover, the FILIP1L, locus showed hypermethylation in human cSCC and lower expression in human cSCC cell lines.
Interpretation: Deregulation of DNA methylation is an important feature of murine and human cSCC that likely contributes to silencing of tumour suppressor genes, as shown for Filip1l. 2021 The Author(s). Published by Elsevier B.V.}},
  articleno    = {{103383}},
  author       = {{Roth, Kevin and Coussement, Louis and Knatko, Elena V. and Higgins, Maureen and Steyaert, Sandra and Proby, Charlotte M. and De Meyer, Tim and Dinkova-Kostova, Albena T.}},
  issn         = {{2352-3964}},
  journal      = {{EBIOMEDICINE}},
  keywords     = {{cSCC,DNA methylation,RRBS,FILIP1L,INTERACTING PROTEIN 1-LIKE,DOWN-REGULATION,SKIN-CANCER,MUTATIONS,CARCINOGENESIS,INHIBITION,EXPRESSION,LANDSCAPE,RADIATION,BENEFITS}},
  language     = {{eng}},
  pages        = {{12}},
  title        = {{Clinically relevant aberrant Filip1l DNA methylation detected in a murine model of cutaneous squamous cell carcinoma}},
  url          = {{http://doi.org/10.1016/j.ebiom.2021.103383}},
  volume       = {{67}},
  year         = {{2021}},
}

Altmetric
View in Altmetric
Web of Science
Times cited: